Arzeda
Pre-clinicalArzeda, the leading Protein Design Company™, leverages AI-driven protein design to deliver innovative designer proteins and enzymes at commercial scale, transforming industries with cutting-edge solutions.
Founded
2008
Focus
Synthetic BiologyAI / Machine Learning
About
Arzeda, the leading Protein Design Company™, leverages AI-driven protein design to deliver innovative designer proteins and enzymes at commercial scale, transforming industries with cutting-edge solutions.
Funding History
3Total raised: $52M
Series B$35MBoehringer Ingelheim Venture FundSep 15, 2023
Series A$15MOS FundJul 15, 2020
Seed$2MOS FundApr 15, 2018
Company Info
TypePrivate
Founded2008
LocationSeattle, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile